762. Real-World Utilization of C. difficile Drug Treatments and Associated Clinical Outcomes in a US Hospital System

BACKGROUND: IDSA recommends use of fidaxomicin or oral vancomycin for treatment of initial episode or first recurrence of Clostridioides difficile infection (CDI). This study aimed to evaluate impact of a clinical decision support order set driving appropriate use of fidaxomicin on utilization of CD...

Descripción completa

Detalles Bibliográficos
Autores principales: McDaniel, Lauren, Everson, Nathan, White, Melissa, Obi, Engels N, Chen, Yiyun, Kohinke, Rose, Lockhart, Ellen Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644007/
http://dx.doi.org/10.1093/ofid/ofab466.959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644007/
http://dx.doi.org/10.1093/ofid/ofab466.959

Ejemplares similares